← Back to all trials
Completed
NCT07805837
Comparative Immunologic Mechanisms and Microbiome Interactions Following Different Influenza Vaccine Formulations in Older Adults
Conditions: Influenza, Influenza Vaccines, Microbiome, Immune Response
Sex: All
Ages: 65 Years – N/A
Healthy volunteers: Yes
Phase: PHASE4
Enrollment: 121
Sponsor: Korea University Guro Hospital
Location: Korea University Guro Hospital Seoul Seoul
Summary
This prospective, randomized, open-label clinical study aims to evaluate the immunogenicity and underlying immune mechanisms of different influenza vaccine formulations in adults aged ≥65 years. Additionally, the study investigates the role of the gut microbiome in modulating vaccine-induced immune responses and durability.
Eligibility Criteria
Inclusion Criteria:
* Age ≥65 years
* Able and willing to provide informed consent
Exclusion Criteria:
* Influenza vaccination within the past 6 months
* Laboratory-confirmed influenza infection within the past 6 months
* Immunocompromised status
* Uncontrolled chronic medical conditions
Source: ClinicalTrials.gov (NCT07805837). StuddyBuddy aggregates publicly available trial information.